Srdjan R. Stankovic - Net Worth and Insider Trading
Srdjan R. Stankovic Net Worth
The estimated net worth of Srdjan R. Stankovic is at least $1 Million dollars as of 2024-09-21. Srdjan R. Stankovic is the President of ACADIA Pharmaceuticals Inc and owns about 61,234 shares of ACADIA Pharmaceuticals Inc (ACAD) stock worth over $1 Million. Details can be seen in Srdjan R. Stankovic's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Srdjan R. Stankovic has not made any transactions after 2022-11-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Srdjan R. Stankovic
Srdjan R. Stankovic Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Srdjan R. Stankovic owns 1 companies in total, including ACADIA Pharmaceuticals Inc (ACAD) .
Click here to see the complete history of Srdjan R. Stankovic’s form 4 insider trades.
Insider Ownership Summary of Srdjan R. Stankovic
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ACAD | ACADIA Pharmaceuticals Inc | 2022-11-21 | EVP |
Srdjan R. Stankovic Latest Holdings Summary
Srdjan R. Stankovic currently owns a total of 1 stock. Srdjan R. Stankovic owns 61,234 shares of ACADIA Pharmaceuticals Inc (ACAD) as of November 21, 2022, with a value of $1 Million.
Latest Holdings of Srdjan R. Stankovic
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ACAD | ACADIA Pharmaceuticals Inc | 2022-11-21 | 61,234 | 16.53 | 1,012,198 |
Holding Weightings of Srdjan R. Stankovic
Srdjan R. Stankovic Form 4 Trading Tracker
According to the SEC Form 4 filings, Srdjan R. Stankovic has made a total of 19 transactions in ACADIA Pharmaceuticals Inc (ACAD) over the past 5 years, including 0 buys and 19 sells. The most-recent trade in ACADIA Pharmaceuticals Inc is the sale of 1,847 shares on November 21, 2022, which brought Srdjan R. Stankovic around $27,834.
Insider Trading History of Srdjan R. Stankovic
- 1
Srdjan R. Stankovic Trading Performance
Srdjan R. Stankovic Ownership Network
Srdjan R. Stankovic Owned Company Details
What does ACADIA Pharmaceuticals Inc do?
Who are the key executives at ACADIA Pharmaceuticals Inc?
Srdjan R. Stankovic is the EVP of ACADIA Pharmaceuticals Inc. Other key executives at ACADIA Pharmaceuticals Inc include EVP & COO & Head of Commercial Brendan Teehan , director & PRESIDENT AND CEO Stephen Davis , and Chief Financial Officer Mark C. Schneyer .
ACADIA Pharmaceuticals Inc (ACAD) Insider Trades Summary
Over the past 18 months, Srdjan R. Stankovic made no insider transaction in ACADIA Pharmaceuticals Inc (ACAD). Other recent insider transactions involving ACADIA Pharmaceuticals Inc (ACAD) include a net sale of 336,324 shares made by Stephen Davis , a net sale of 56,441 shares made by Mark C. Schneyer , and a net sale of 44,202 shares made by Brendan Teehan .
In summary, during the past 3 months, insiders sold 51,014 shares of ACADIA Pharmaceuticals Inc (ACAD) in total and bought 0 shares, with a net sale of 51,014 shares. During the past 18 months, 479,545 shares of ACADIA Pharmaceuticals Inc (ACAD) were sold and 896,522 shares were bought by its insiders, resulting in a net purchase of 416,977 shares.
ACADIA Pharmaceuticals Inc (ACAD)'s detailed insider trading history can be found in Insider Trading Tracker table.
ACADIA Pharmaceuticals Inc Insider Transactions
Srdjan R. Stankovic Mailing Address
Above is the net worth, insider trading, and ownership report for Srdjan R. Stankovic. You might contact Srdjan R. Stankovic via mailing address: C/o Acadia Pharmaceuticals Inc., 12830 El Camino Real, Suite 400, San Diego Ca 92130.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
